| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |